Jay Venkatesan

Jay Venkatesan

Directeur/Membre du Conseil chez ELICIO THERAPEUTICS, INC.

Fortune : 4 M $ au 30/04/2024

52 ans
Health Technology
Finance
Commercial Services

Provenance du réseau au premier degré de Jay Venkatesan

EntitéType d'entitéIndustrie
176
Private Company Miscellaneous Commercial Services 176
Williams College
125
College/University Other Consumer Services 125
Public Company Biotechnology 24
Public Company Biotechnology 21
Public Company Biotechnology 17
Public Company Biotechnology 13
12
Extinct Biotechnology 12
12
Subsidiary Biotechnology 12
11
Subsidiary Pharmaceuticals: Major 11
10
Subsidiary Investment Managers 10
4
Subsidiary Biotechnology 4
3
Private Company Investment Managers 3
3
Holding Company Miscellaneous Commercial Services 3
2
Private Company Biotechnology 2
Extinct Medical Specialties 2

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Jay Venkatesan via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
ABBOTT LABORATORIES Medical Specialties

Timothy Walbert

Robert Connelly

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Robert Ruffolo

Timothy Walbert

Corporate Officer/Principal

Corporate Officer/Principal

AMGEN INC. Pharmaceuticals: Major

Iain Dukes

Christopher Haqq

Natasha Hernday

Joshua J. Ofman

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Timothy Walbert

Julian Adams

Iain Dukes

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

PHARMACYCLICS, INC. Pharmaceuticals: Major

Maria Fardis

Franco Valle

Corporate Officer/Principal

Comptroller/Controller/Auditor

BIOGEN INC. Pharmaceuticals: Major

Daniel Char

Philip Ma

Annette Matthies

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Helen Kim

Christopher Peetz

Corporate Officer/Principal

Corporate Officer/Principal

Investment Managers

Maria Fardis

Remy Durand

Private Equity Investor

Private Equity Investor

XOMA CORPORATION Pharmaceuticals: Major

Timothy Walbert

Natasha Hernday

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Timothy Morris

James Rickey

Corporate Officer/Principal

Corporate Officer/Principal

College/University

Jeffrey Evenson

Jason Klein

Darren Huston

Brian Goler

A. Steven Walleck

Ned Stringham

Joanna Barsh

Todd Juenger

Doug Lord

Thomas Schmitt

Philip Ma

Doctorate Degree

Masters Business Admin

Masters Business Admin

Undergraduate Degree

Masters Business Admin

Masters Business Admin

Masters Business Admin

Undergraduate Degree

Masters Business Admin

Undergraduate Degree

Undergraduate Degree

Massachusetts Institute of Technology College/University

Julian Adams

Jeffrey L. Cleland

Jeffrey Evenson

Stan Rose

Andra Bolotin

Darrell J. Irvine

Philip Ma

Peter DeMuth

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Graduate Degree

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

College/University

Allen Nissenson

Helen Kim

Chad A. Mirkin

Colby Shad Thaxton

Michael Abecassis

Yekaterina Chudnovsky

Undergraduate Degree

Undergraduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Undergraduate Degree

Harvard Business School College/University

David Snyder

Karen Wilson

Guillermo Marmol

Thomas Schmitt

Jessica Hopfield

Christopher Simon

Masters Business Admin

Corporate Officer/Principal

Masters Business Admin

Masters Business Admin

Masters Business Admin

Masters Business Admin

Stanford University College/University

Christopher Haqq

L. Stephen Coles

Robert Sternfels

Xiang Ming Cui

Remy Durand

Stanford Peng

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Doctorate Degree

Undergraduate Degree

University of Oxford College/University

Iain Dukes

Robert Sternfels

Bali Muralidhar

Philip Ma

Doctorate Degree

Graduate Degree

Doctorate Degree

Graduate Degree

University of California, Berkeley College/University

Karen Wilson

L. Stephen Coles

Joshua J. Ofman

Maria Fardis

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

The University of Chicago College/University

R. Carruthers

Helen Kim

Joanna Barsh

Masters Business Admin

Masters Business Admin

Graduate Degree

The Pennsylvania State University College/University

Chad A. Mirkin

Carol Ashe

Frederick Vogt

Doctorate Degree

Undergraduate Degree

Doctorate Degree

Harvard Law School College/University

Sanford J. Hillsberg

Daniel Char

Geoffrey Darrell Fink

Graduate Degree

Graduate Degree

Graduate Degree

Miscellaneous Commercial Services

Robert Ruffolo

Timothy Walbert

Mitchell Gold

Director/Board Member

Director/Board Member

Director/Board Member

Feinberg School of Medicine College/University

Allen Nissenson

Colby Shad Thaxton

Michael Abecassis

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

Pharmaceuticals: Major

Wayne P. Rothbaum

Iain Dukes

Maria Fardis

Founder

Founder

Director/Board Member

MIRUM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Timothy Walbert

Christopher Peetz

Director/Board Member

Founder

Santa Clara University College/University

Ryan Maynard

Mark Litton

Undergraduate Degree

Masters Business Admin

ARYX THERAPEUTICS, INC. Pharmaceuticals: Major

Paul Sekhri

Stanford Peng

Director/Board Member

Director/Board Member

Tufts University College/University

David Walt

Daniel Char

Corporate Officer/Principal

Undergraduate Degree

University of Michigan College/University

David Walt

Lisa McNeil

Undergraduate Degree

Undergraduate Degree

PDL BIOPHARMA, INC. Biotechnology

Karen Wilson

Natasha Hernday

Director of Finance/CFO

Director/Board Member

University of Colorado Boulder College/University

R. Carruthers

Colby Shad Thaxton

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Generic

Wayne P. Rothbaum

Maria Fardis

Chairman

Chief Operating Officer

Investment Banks/Brokers

Jeffrey Evenson

Todd Juenger

Analyst-Equity

Analyst-Equity

David Geffen School of Medicine College/University

Allen Nissenson

Joshua J. Ofman

Corporate Officer/Principal

Corporate Officer/Principal

Rensselaer Polytechnic Institute College/University

Andra Bolotin

L. Stephen Coles

Undergraduate Degree

Undergraduate Degree

Packaged Software

Bosun Hau

Bali Muralidhar

Director/Board Member

Director/Board Member

University of Utah College/University

Ned Stringham

Charles Chase

Undergraduate Degree

Doctorate Degree

University of Maryland College/University

Paul Sekhri

Peter DeMuth

Undergraduate Degree

Undergraduate Degree

AXCA HEALPAR Biotechnology

Paul Sekhri

Robert Connelly

Director/Board Member

Chief Executive Officer

GSK PLC Pharmaceuticals: Major

Robert Ruffolo

Carol Ashe

Corporate Officer/Principal

Corporate Officer/Principal

Yale University College/University

Geoffrey Darrell Fink

Stanford Peng

Undergraduate Degree

Doctorate Degree

University of Pennsylvania College/University

Sanford J. Hillsberg

Joanna Barsh

Undergraduate Degree

Undergraduate Degree

College/University

Mitchell Gold

James Rickey

Director/Board Member

Graduate Degree

Electronic Equipment/Instruments

Joshua J. Ofman

Xiang Ming Cui

Chief Tech/Sci/R&D Officer

Director/Board Member

Miscellaneous Commercial Services

Mitchell Gold

Christopher Peetz

Director/Board Member

Corporate Officer/Principal

SEAGEN INC. Pharmaceuticals: Major

Natasha Hernday

Stanford Peng

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Statistiques

Internationale

Etats-Unis 46
Royaume-Uni 3
Israël 2
Pays-Bas 2

Sectorielle

Consumer Services 22
Health Technology 21
Finance 4
Commercial Services 4
Technology Services 2

Opérationnelle

Director/Board Member 431
Corporate Officer/Principal 239
Chief Executive Officer 102
Independent Dir/Board Member 94
President 92
  1. Bourse
  2. Insiders
  3. Jay Venkatesan
  4. Connexions Sociétés
-40% Offre à Durée Limitée : Nos abonnements vous guident vers les meilleurs investissements de demain.
PROFITEZ-EN MAINTENANT